Zhong Zheng

Zhong Zheng

Auto-generated profile, based on publicly available information

Zhong Zheng

Institute of Molecular Medicine, Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, Department of Urology, Department of pathology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2024 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
JCJiao Cao
Jiao Cao
ZZZhong Zheng
Zhong Zheng
DSDi Sun
Di Sun
XCXin Chen
Xin Chen
RCRui Cheng
Rui Cheng
Chaoyong YangChaoyong Yang
Chaoyong Yang

1 September 2009 in Cancer Biology & Therapy
Verified
Journal Article
Open access
JGJingchun Gao
Jingchun Gao
ZZZhong Zheng
Zhong Zheng
BRBhupendra Rawal
Bhupendra Rawal
MSMichael Schell
Michael Schell
GBGerold Bepler
Gerold Bepler
EHEric Haura
Eric Haura
Minibrain-related kinase (Mirk) is a member of the dual specificity tyrosine- phosphorylation-regulated kinase (Dyrk)/minibrain family of dual-specificity protein kinases and is identical to Dyrk1B...

21 August 2020 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
ZZZhong Zheng
Zhong Zheng
ZYZhixian Yao
Zhixian Yao
KWKe Wu
Ke Wu
JZJunhua Zheng
Junhua Zheng

1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
ZZZhong Zheng
Zhong Zheng
XZXinyi Zheng
Xinyi Zheng
YZYiwen Zhu
Yiwen Zhu
ZYZhixian Yao
Zhixian Yao
WZWeiguang Zhao
Weiguang Zhao
JZJunhua Zheng
Junhua Zheng
Muscle‐invasive bladder cancer (MIBC) is characterized by a highly complex immune environment, which is not well understood. Interleukin‐6 (IL‐6) is generated and secreted by multifarious types of cells, including tumor cells. This study was aimed at demonstrating that the levels of IL‐6 and the number of myeloid‐derived suppressor cells (MDSCs), with a positive correlation between them, increased in MIBC tissues, promoting MIBC cell proliferation, especially in patients with recurrence. In coculture analysis, MDSCs, with the stimulation of IL‐6, could significantly lower the proliferation ability of CD4+ or CD8+ T lymphocytes. Further, this study demonstrated that IL‐6 could upregulate the mitogen‐activated protein kinase (MAPK) signaling pathway in MDSCs. The MAPK signaling inhibitor, aloesin, partially reversed the effects of IL‐6 on MDSCs. These data suggested that IL‐6 promoted MIBC progression by not only accelerating proliferation but also improving the immune suppression ability of MDSCs through activating the MAPK signaling pathway.

1 July 2020 in Journal of Clinical Virology
Verified
Journal Article
Closed access
ZZZhong Zheng
Zhong Zheng
ZYZhixian Yao
Zhixian Yao
KWKe Wu
Ke Wu
JZJunhua Zheng
Junhua Zheng

25 October 2023 in Cellular Oncology
Verified
Journal Article
Closed access
PDF file
KWKe Wu
Ke Wu
YLYaorong Li
Yaorong Li
KMKangli Ma
Kangli Ma
WZWeiguang Zhao
Weiguang Zhao
ZYZhixian Yao
Zhixian Yao
JZJunhua Zheng
Junhua Zheng